中国神经再生研究(英文版)

中国神经再生研究(英文版) ›› 2012, Vol. 7 ›› Issue (6): 434-439.

• 原著:脑损伤修复保护与再生 • 上一篇    下一篇

Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack

  

  • 收稿日期:2011-09-24 修回日期:2011-12-22 出版日期:2012-02-25 发布日期:2012-02-25

Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack

Donglin Jiang, Xing Chu, Lingling Hu, Shengyang Jiang, Feng Hu, Junming Sun, Chengwan Li   

  1. The Third Affiliated Hospital of Nantong University, Wuxi 214000, Jiangsu Province, China
  • Received:2011-09-24 Revised:2011-12-22 Online:2012-02-25 Published:2012-02-25
  • Contact: Xing Chu, Chief physician, the Third Affiliated Hospital of Nantong University, Wuxi 214000, Jiangsu Province, China jdlstar@126.com
  • About author:Donglin Jiang★, Master, Associate chief technician, the Third Affiliated Hospital of Nantong University, Wuxi 214000, Jiangsu Province, China

PDF

858

Abstract:

Patients with mild cognitive impairment after a transient ischemic attack were included in this study. They were treated with Yizhi Xingnao prescription, ergoloid mesylates or aspirin for 60 days. Evaluation using the Montreal Cognitive Assessment Scale showed that cognitive function was significantly improved in all patients, especially after the combined treatment of Yizhi Xingnao and aspirin. The scores from the Montreal Cognitive Assessment Scale were improved overall and the effective treatment rate was as high as 79%, which was higher than patients treated with a combination of ergoloid mesylates and aspirin, or aspirin alone. Our experimental findings indicate that Yizhi Xingnao prescription can improve mild cognitive impairment after a transient ischemic attack, and that it is more effective than ergoloid mesylates.

Key words: Yizhi Xingnao prescription, transient ischemic attack, mild cognitive impairment, Montreal Cognitive Assessment Scale, ergoloid mesylates, aspirin